Published in Fam Cancer on September 01, 2015
Systematic review of peer-support programs for people with cancer. Patient Educ Couns (2008) 2.22
What do cancer support groups provide which other supportive relationships do not? The experience of peer support groups for people with cancer. Soc Sci Med (2005) 1.69
Cancer peer support programs-do they work? Patient Educ Couns (2004) 1.58
The effect of peer counseling on quality of life following diagnosis of breast cancer: an observational study. Psychooncology (2006) 1.56
Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol (1997) 1.46
Effect of Internet peer-support groups on psychosocial adjustment to cancer: a randomised study. Br J Cancer (2010) 1.36
A qualitative study of breast cancer self-help groups. Psychooncology (1997) 1.25
Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer (2002) 1.21
A randomized, controlled study of Internet peer-to-peer interactions among women newly diagnosed with breast cancer. Psychooncology (2010) 1.18
An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. J Med Genet (2000) 1.02
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol (2007) 0.96
The experience and impact of chronic disease peer support interventions: a qualitative synthesis. Patient Educ Couns (2013) 0.90
The potential of cellular technology to mediate social networks for support of chronic disease self-management. J Health Commun (2011) 0.89
Senior peer counseling by telephone for psychosocial support after breast cancer surgery: effects at six months. Oncol Nurs Forum (2012) 0.87
Can a tailored telephone intervention delivered by volunteers reduce the supportive care needs, anxiety and depression of people with colorectal cancer? A randomised controlled trial. Psychooncology (2011) 0.85
Randomized controlled trial of a telephone-based peer-support program for women carrying a BRCA1 or BRCA2 mutation: impact on psychological distress. J Clin Oncol (2014) 0.82
Telephone peer support for women with gynaecological cancer: benefits and challenges for supporters. Psychooncology (2012) 0.81
The Unmet Information and Support Needs of Women with a Family History of Breast Cancer: A Descriptive Survey. J Genet Couns (2003) 0.79
Unmet support needs and distress among women with a BRCA1/2 mutation. Fam Cancer (2013) 0.78
Identification of traumatic stress reactions in women at increased risk for breast cancer. Psychosomatics (2004) 0.77
What models of peer support do people with colorectal cancer prefer? Eur J Cancer Care (Engl) (2010) 0.76
Impact of tobacco control policies and mass media campaigns on monthly adult smoking prevalence. Am J Public Health (2008) 3.72
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology (2008) 3.35
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06
Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol (2006) 2.46
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. J Natl Cancer Inst (2012) 2.44
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood (2002) 2.30
Systematic review of peer-support programs for people with cancer. Patient Educ Couns (2008) 2.22
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
Pancreatic cancer: surgical management and outcomes after 6 years of follow-up. Med J Aust (2012) 2.12
Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med (2009) 1.85
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol (2005) 1.77
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol (2007) 1.74
The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med (2007) 1.74
A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res (2010) 1.68
Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology (2006) 1.66
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening? J Clin Oncol (2007) 1.66
Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma. J Clin Endocrinol Metab (2013) 1.61
Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. J Clin Oncol (2006) 1.56
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat (2009) 1.52
Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs. BJU Int (2013) 1.50
Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey. J Oncol Pract (2008) 1.49
Adolescents' use of purpose built shade in secondary schools: cluster randomised controlled trial. BMJ (2009) 1.47
Usefulness of the Threatening Medical Situations Inventory in individuals considering genetic testing for cancer risk. Patient Educ Couns (2007) 1.44
Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer (2005) 1.42
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial. J Clin Oncol (2009) 1.40
Can home smoking restrictions influence adolescents' smoking behaviors if their parents and friends smoke? Addict Behav (2006) 1.39
Melanoma(s) arising in large segmental speckled lentiginous nevi: a case series. J Am Acad Dermatol (2011) 1.39
The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. J Cancer Surviv (2009) 1.36
Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs). Hum Mutat (2010) 1.33
Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust (2003) 1.32
Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol (2006) 1.32
How to catch all those mutations--the report of the third Human Variome Project Meeting, UNESCO Paris, May 2010. Hum Mutat (2010) 1.31
Investigating the relation between placement of Quit antismoking advertisements and number of telephone calls to Quitline: a semiparametric modelling approach. J Epidemiol Community Health (2006) 1.27
Public interest in predictive genetic testing, including direct-to-consumer testing, for susceptibility to major depression: preliminary findings. Eur J Hum Genet (2010) 1.26
It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. J Clin Oncol (2011) 1.20
Attitudes toward organ donation and donor behavior: a review of the international literature. Prog Transplant (2010) 1.20
Educating genetic counselors in Australia: developing an international perspective. J Genet Couns (2005) 1.18
The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol (2010) 1.18
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand. Cancer Immun (2004) 1.15
Controversies and ethical issues in cancer-genetics clinics. Lancet Oncol (2005) 1.15
The fertility- and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology (2003) 1.14
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment option. J Clin Oncol (2009) 1.12
Toward cultural competence in cancer genetic counseling and genetics education: lessons learned from Chinese-Australians. Genet Med (2006) 1.10
Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat (2010) 1.10
Dietary, physical activity and sedentary behaviour among Australian secondary students in 2005. Health Promot Int (2007) 1.10
Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families. Genet Med (2009) 1.10
Effectively discussing complementary and alternative medicine in a conventional oncology setting: communication recommendations for clinicians. Patient Educ Couns (2009) 1.10
Appropriate, timely referral to palliative care services: a name change will not help. J Clin Oncol (2013) 1.09
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res (2013) 1.09
Improving survivorship care. J Clin Oncol (2012) 1.08
IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J Immunol (2002) 1.06
Rational approaches to human cancer immunotherapy. J Leukoc Biol (2003) 1.05
Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases. Cancer Epidemiol Biomarkers Prev (2013) 1.05
Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Nephrol Dial Transplant (2005) 1.04
Issues concerning feedback about genetic testing and risk of depression. Br J Psychiatry (2009) 1.04
A bridge between cultures: interpreters' perspectives of consultations with migrant oncology patients. Support Care Cancer (2010) 1.03
PALB2 and breast cancer: ready for clinical translation! Appl Clin Genet (2013) 1.03
Preliminary results of 2009 pandemic influenza surveillance in the United States using the Aggregate Hospitalization and Death Reporting Activity. Influenza Other Respir Viruses (2011) 1.03
Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol (2013) 1.03
Dynamic consent in the digital age of biology: online initiatives and regulatory considerations. J Prim Health Care (2013) 1.03
Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol (2008) 1.02
Insurance repercussions of mammographic screening: what do women think? Med Sci Monit (2002) 1.02
From inside the bubble: migrants' perceptions of communication with the cancer team. Support Care Cancer (2010) 1.01
Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer (2008) 1.01
Reconciling population benefits and women's individual autonomy in mammographic screening: in-depth interviews to explore women's views about 'informed choice'. Aust N Z J Public Health (2005) 1.00
Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy. Genet Med (2013) 1.00
Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat (2002) 0.97
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. Breast Cancer Res Treat (2007) 0.97
Women's experience of telehealth cancer genetic counseling. J Genet Couns (2010) 0.97
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat (2007) 0.97
Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study. Psychooncology (2007) 0.97
Importance of health literacy in oncology. Asia Pac J Clin Oncol (2012) 0.96
Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer (2010) 0.96
Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol (2011) 0.95
Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res (Phila) (2011) 0.95
Comparative mapping in watermelon [Citrullus lanatus (Thunb.) Matsum. et Nakai]. Theor Appl Genet (2012) 0.95
"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer. Genet Test Mol Biomarkers (2011) 0.95
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiol Biomarkers Prev (2004) 0.94
Phenotype in novel Xp duplication. Am J Med Genet A (2012) 0.94
Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One (2012) 0.93
Evaluation of a decision aid for prenatal testing of fetal abnormalities: a cluster randomised trial [ISRCTN22532458]. BMC Public Health (2006) 0.93
Preparing patients for threatening medical treatments: effects of a chemotherapy educational DVD on anxiety, unmet needs, and self-efficacy. Support Care Cancer (2007) 0.93
Better the devil you know? High-risk individuals' anticipated psychological responses to genetic testing for melanoma susceptibility. J Genet Couns (2006) 0.93
A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psychooncology (2008) 0.93
The Australasian Colorectal Cancer Family Registry. Med J Aust (2012) 0.93
Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genet Med (2011) 0.92
Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? Eur J Cancer (2013) 0.92
Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns (2007) 0.91
Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust (2009) 0.91
Predictive and diagnostic genetic testing in psychiatry. Clin Lab Med (2010) 0.91
Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: a population-based study. Eur J Cancer (2013) 0.90
Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psychooncology (2005) 0.90
Sun exposure and sun protection behaviours among Australian adolescents: trends over time. Prev Med (2003) 0.89
Psychological morbidity in women at increased risk of developing breast cancer: a controlled study. Psychooncology (2005) 0.89
Information about cancer clinical trials: an analysis of Internet resources. Eur J Cancer (2007) 0.89
100 years Lynch syndrome: what have we learned about psychosocial issues? Fam Cancer (2013) 0.89